“AIDS Healthcare Foundation (AHF) continues to sound the alarm that a nationwide drug discount pricing program vital to the country’s health care safety net – and its HIV/AIDS response – is once again under attack by the drug industry under the guise of ‘reform.’

This week, AHF issued an ‘Open Letter’ to U.S. Representative Scott Peters (D-CA, 52nd District) asking that he reconsider his sponsorship of H.R. 4710, known as The PAUSE Act, a bill that stops new, eligible hospitals from joining the 340B drug pricing program. 340B has helped provide low-cost medications and better health outcomes for millions of Americans and the non-profit clinics and hospitals that serve them.

Since December, when Congressman Peters and U.S. Representative Larry Bucshon, M.D. (R-IN, 8th District) first introduced federal legislation attacking the 340B program—a program which costs the government and taxpayers nothing—advocates from AHF and others have been mounting a vigorous advocacy campaign to dispel the myths and pharma-driven falsehoods behind the bill and to urge the two congressmen to pull the legislation. This advocacy has included protests and press conferences held in front of the district offices of both legislators (in CA and IN) as well as the placement of radio, television and online advertisements about the misguided legislation and the 340B program targeting constituents of both congressmen in their respective districts.”

Read More: https://www.businesswire.com/news/home/20180403005946/en/AHF-Demands-U.S.-Rep.-Scott-Peters-D-CA

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields